This case expands the spectrum of disease associated with <i>BRAT1</i> variants and highlights the utility of genetic testing to identify the cause of developmental and epileptic encephalopathies where clinical heterogeneity within a spectrum of disease exists. Here, BRAT1 is linked to Epileptic encephalopathy.